OwnersBox Hires New VP of Sales & Partnerships, Daniel White

TORONTO, ONTARIO, CANADA , March 2, 2021 /EINPresswire.com/ — OwnersBox is ecstatic to announce that they have hired Daniel White as the Vice President of Sales & Partnerships.

Daniel joins the OwnersBox team after 12 years at MLSE (Maple Leaf Sports & Entertainment), where he was the Senior Account Executive who lead the team in sales, generating over $1 million annually. He was also responsible for generating key partnerships for the Raptors brand, such as the naming rights to the OVO Athletic Centre (Raptors practice facility). Daniel also played an integral role in selling out the Sher Club, an exclusive member-only space at Scotiabank Arena in partnership with Drake.

When asked for comment on the new role, Daniel said, "I'm very excited to join an amazing team with a unique product in the effort to carve out a segment in the paid Fantasy Sports market. I can't wait to take my 12 years of experience in the sports industry and utilize it to grow OwnersBox to a level that we've never been before. I'm very passionate about the platform and love the socially-driven Weekly Fantasy Sports product that made this opportunity a no-brainer."

Daniel will play a major role in scaling up partnership & affiliate program efforts for OwnersBox.

Website: www.ownersbox.com
Facebook: @OwnersBoxFantasySports
Instagram: @OwnersBox
Twitter: @OwnersBox

Sandy Plashkes
OwnersBox
+1 619-955-3800
email us here


Source: EIN Presswire

This Startup wants every American to have a lawyer on retainer

JUSTLAW founder Jason Gabbard

Jason Gabbard, one of the founders of JUSTLAW

JUSTLAW, the world's most beloved legal brand

JUSTLAW logo

…the real spin here is the use of technology, 24/7 access, asynchronous chat and their matching algorithms. That’s the game changer.”

— Joseph Lonetto

NEW YORK CITY, NY, UNITED STATES, March 2, 2021 /EINPresswire.com/ — Launched in 2020 in the face of the worst pandemic in a century, JUSTLAW started with the lofty vision to give ordinary Americans access to top attorneys on a 24/7 basis. It’s working. The upstart has notched multiple months of 100%+ growth.

Legal scholars have estimated there are approximately 238 million unsolved household legal problems in the United States right now, despite there being over 1.2 million licensed attorneys. And unfortunately, most of those problems fall on the shoulders of working class Americans, not the one percenters.
JUSTLAW aims to deliver an antidote to this broken model.

“There’s been a lot of displacement in the market, with job loss, unpaid rents, mortgages in arrears, and generally anxiety and stress, which may have been there before,” says founder Jason Gabbard. “But it’s definitely been exacerbated by the pandemic. That's definitely blown some wind into our sails."

JUSTLAW lets people connect with lawyers over the web, via SMS, video or phone. The company's legal wellness plans — which start at less than $5 a week – allow customers to match with a lawyer who is in their jurisdiction, has expertise in the problem with which they’re dealing, and has availability when you need to talk. There’s also a first-of-its-kind 2-way rating system being built which will let you rate your lawyer much like you do your Lyft driver. If a lawyer falls below the company's rating threshold, she's removed from the network.

“We think affordable legal services and access to justice are not just something people should have, it’s something our constitution promises us,” a company spokesperson said, adding “it’s crazy that this hasn’t already been done.”

It isn’t clear if the customers are signing up because of COVID or because of general legal issues these days, Gabbard points out.

The company is also seeing more millennials requesting services. A surprise, Gabbard notes. A lot of millennials come to the company looking to protect their pets and their digital assets – like YouTube and TikTok accounts, especially the influencer set. Many in this set aim to use bespoke planning documents to essentially set up "dead-hand" control over digital assets, and establish funds and guardianship arrangements for their beloved pets; lots of seemingly non-traditional planning exercises, a company spokesperson notes. Gabbard says this group is, in many cases, drawn in by the cool branding and tech focus, but also genuinely interested in and motivated by the Company’s public benefit arm, JUSTCARE, which gives a percentage of its profits and attorney time back to the communities in which they operate.

The idea isn't new. The old Prepaid Legal built a network of attorneys back in the 1970s and allowed people to tap into the network for a monthly fee. But as Joseph Lonetto, a New York City-based attorney, suggests, the real spin here is the use of technology, 24/7 access, asynchronous chat and their matching algorithms. “That’s the game changer”, Lonetto goes on to note.

According to insiders at the company, a small business offering is in the works with a major partnership in place to help with distribution.

Whether JUSTLAW can make a dent in the 238 million legal problems Americans have right now remains to be seen, but they’re definitely off to a good start.

Roman
Supers
+1 888-587-8187
email us here
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

STEREO DIVE FOUNDATION REVEALS HOVERING SENSATIONAL TRACK “INDIGO & TANGERINE”

JAPAN's STEREO DIVE FOUNDATION REVEALS HOVERING SENSATIONAL TRACK “INDIGO & TANGERINE” AVAILABLE NOW ON ALL MUSIC STREAMING PLATFORMS WORLDWIDE.

LOS ANGELES, CA, UNITED STATES OF AMERICA, March 2, 2021 /EINPresswire.com/ — Producer, Singer-Songwriter R・O・N’s project STEREO DIVE FOUNDATION has dropped a new track called “Indigo & Tangerine” on February 24th (Wed) that had been included in the EP “STORYSEEKER” upon the pressed CD version release. The track had also been revealed world-wide on all music streaming platforms including Spotify, Apple Music, and more on the same day.

STEREO DIVE FOUNDATION's latest revealed track "Indigo & Tangerine" is a hovering sensation with mixture of colorful heavy EDM and its uplifting vibes made for the most ideal feel-good vibe. The sound design elite mixes various genres from chill drop to future bass feels uniquely blending it to the point where you could be unconsciously closing your eyes feeling the movement.

"It's a song that you can imagine it as if the sun is about to rise. Indigo=blue and Tangerine=red, orange. It's exactly that sky color you see at that timing and you could also start hearing sounds as if the insects were singing at night. " says R・O・N

The EP title song “STORYSEEKER” had also been selected as the official Ending Theme song for the popular T.V. Anime Series “That Time I Got Reincarnated as a Slime -Season 2”. That Time I Got Reincarnated as a Slime is a media mix project ​​based on the WEB novel written by Fuse on the online novel posting site, “Shousetsuka ni Narou” Abbreviated as TenSura.

STEREO DIVE FOUNDATIONS previous work “ALPHA” reached more than 1 million views globally on YouTube in less than a month since its release and has received numerous supports by listeners all over the world on music streaming sites. Following the footsteps, the music video for “STORYSEEKER” has also hit 1M views just in 3 weeks.

STREAM "INDIGO & TANGERINE" HERE: https://smarturl.it/sdf_it

FOR MEDIA: HERE FOR PRESS ASSETS

CONNECT WITH STEREO DIVE FOUNDATION:
Official Website: https://stereodivefoundation.jp/
Instagram: https://www.instagram.com/RON_SDF/
Twitter: https://twitter.com/RON_SDF
Youtube: https://www.youtube.com/channel/UCYcU_nMWcPrpmz5FmiGf0UA
Spotify:https://open.spotify.com/track/2HiESMuQNg0EbaYMdZ8gNK?si=jJazYULkQhq5SaLpI97rHQ
Apple Music: https://music.apple.com/us/artist/stereo-dive-foundation/740504796

About STEREO DIVE FOUNDATION:

STEREO DIVE FOUNDATION is the sound making project of songwriter/music producer and former rock band OLDCODEX member R・O・N who produces various sound contents and music for varieties of popular Japanese artists and Anime.

This project was named with the meaning of entrusting himself to the stereo, which is the sound source. In addition to his talent as a multi-player of various musical instruments, he also is a Sound Artisan who produces a track with the futuristic synth work and a melody that will resonate with your heart.

R・O・N himself sings on the project's songs, but also welcomes guest vocalists and guest musicians actively with the style of having the flexibility to correspond to what the world is in demand. R・O・N has been reputable for his distinct programming arrangements with it being able to adapt to various genres of music along with his catchy and artistic sounds. R・O・N has over 100K listeners on his Spotify and his song “Chronos” have streamed over 1100K. 

He will do whatever it takes to express his desired sounds with his incredible sense, regardless of any method. This is STEREO DIVE FOUNDATION.

Justin Takada
JUS. Management
justin@jusmanagement.com


Source: EIN Presswire

HEALING A COMMUNITY

The Lovelock Dispensary

The Lovelock Dispensary

Helping restore economic vitality to the Lovelock Reservation through medical cannabis entrepreneurship

RENO, NV, UNITED STATES, March 2, 2021 /EINPresswire.com/ — For many patients, medical marijuana helps heal their personal pain, but for Nevada’s Lovelock Pauite tribe, cannabis is economically healing their community.

“Before we started working with cannabis, we didn’t generate any income and were just dependent on federal funding,” explained Stephanie Rhodes, the former chairwoman for the tribe. “The dispensary and grow center has brought us income and united the tribe members. We have hope and we see we can achieve.”

Working with Tribal Cannabis Consultants the Lovelock community established a dispensary and cultivation center that today employs nearly 20 individuals like Sage Bonta.

Bonta, 24-years-old, had never really considered what he’d be when he grew up before the cannabis businesses came to the community. Two years ago he started as a bud tender and today is program manager of the grow facility with his eye on growing in the industry and the community.

“The sky’s the limit here now,” Bonta said. “There is so much room for advancement.”

According to Rhodes, the income generated from the cannabis businesses allows the tribe to repair homes, provide essentials for the elders, arrange monthly senior outings and put money into educating the next generation.

“Over the years the cannabis businesses can generate hundreds of thousands of dollars of tax revenue for a tribe,” said Cassandra Dittus, president of Tribal Cannabis Consultants.

“The cannabis businesses has helped us provide social services that we don’t get grant money for,” said Rochelle Desot, vice chairwoman of the tribe and trim and packaging manager of their grow facility.

While there were initially mixed emotions in the tribe about getting involved in cannabis, educating the community about the healing benefits of cannabis got their buy-in.

“It’s been such a good opportunity for us in terms of income and growth,” said Sandra Winap, chairwoman of the tribe. “It’s such an open field and we can move in so many directions to continue to grow.”

For more information on how Tribal Cannabis Consultants is changing the economic reality on Native American reservations and/or to arrange interviews, please contact me at dena@provenmediaservices.com

###

About Tribal Cannabis Consulting:
Tribal Cannabis Consulting was founded in Nevada in 2015. The agency provides quality solutions to native and non-native businesses to start or further their existence in the marijuana industry by providing a full spectrum of services, from capital investments and funding development strategies, to consultations and complete development partnerships. The company’s team of expert consultants include former industry owners and operators from throughout the United States that understand the unique challenges marijuana businesses on tribal lands face today. For more information, visit tribalcannabisconsulting.com

Tribal Cannabis Consulting Contact:
Cassandra Dittus, Co-Founder & President, cdittus970@gmail.com.

Media Contact:
Dena Roché
dena@provenmediaservices.com – 602.859.0190

Dena Roche
Proven Media
+1 6028590190
dena@provenmediaservices.com


Source: EIN Presswire

Sunshine Biopharma (Stock Symbol: SBFM) Taking Leading Steps on Virus and Cancer Treatments. 2 Million financing placed

SUNSHINE BIOPHARMA

SBFM STOCK PRICE CHART

$SBFM and the University of Georgia

$SBFM and the University of Georgia

$SBFM products

$SBFM products

Sunshine Biopharma (#Stock Symbol: $SBFM) Taking Leading Steps on #Virus #Covid #Cancer #Treatments
$2 Million Financing in Place, Uplisting to OTCQB Tier

SUNSHINE BIOPHARMA INC (OTCMKTS:SBFM)

We are thrilled to introduce www.Sunshinebiopharma.com, which allows customers to shop reliable tested nutritional supplements anytime.
SBFM will feature nutritional products valued by everyone.”

— Camille Sebaaly, CFO

POINTE-CLAIRE, QUEBEC, CANADA, March 2, 2021 /EINPresswire.com/ — Sunshine Biopharma (#Stock Symbol: $SBFM) Taking Leading Steps on Virus, Covid and Cancer Treatments

$2 Million Financing in Place, Uplisting to OTCQB Tier

 BioPharma Company with Worldwide Patents on Effective Cancer Drugs.
 Joint Agreement to Advance Cancer Treatment to Clinical Trials in Canada.
 Transgenic Mice Study Underway to Advance Covid-19 Treatment.
 Covid Treatment Expected to be Effective Against New Virus Variants.
 Application Completed for Up-Listing to the OTCQB Market Tier.
 $2,000,000 + Financing for Coronavirus Treatment Program.

Sunshine Biopharma (OTC: SBFM) is a Pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, SBFM is engaged in the development and commercialization of science-based nutritional supplements and is also currently engaged in the development of a new pharmaceutical to treat infections of the Covid-19 Coronavirus.

Since inception, SBFM has been involved in the development of Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). SBFM is a direct owner of all worldwide patents covering Adva-27a, including all issued and pending patents.

 SBFM Initiates COVID-19 Treatment Mice Study

On February 10th SBFM announced that it has initiated a momentous transgenic mice study of its COVID-19 treatment that has been under development since May of last year. The SBFM COVID-19 treatment consists of a series of small molecules which suppress replication of the virus by inhibiting a key virus encoded protease that is responsible for compromising the immune system of infected patients. The mice studies are currently underway at the University of Georgia, College of Pharmacy.

On February 4th SBFM announced it had signed an exclusive license agreement with the University of Georgia ("UGA") for two Anti-Coronavirus compounds which UGA had previously developed and patented. SBFM and UGA will advance the development of these two compounds in parallel with the company’s SBFM-PL4.

The mice being used in the study have been genetically engineered to express the human angiotensin-converting enzyme 2 (hACE2) transmembrane protein in their lungs making them susceptible to lethal infection by SARS-CoV-2, the causative agent of COVID-19. The SARS-CoV-2 virus uses the hACE2 receptor to gain entry into human cells to replicate. The goal of the study is to determine if the SBFM protease inhibitors will protect the hACE2-transgenic mice from disease progression and death following infection with SARS-CoV-2 virus.

 SBFM Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033

On February 2nd SBFM announced that it has received a "Notice of Allowance" from the Canadian Intellectual Property Office for a new patent application covering Adva-27a, the Company's flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Canada until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The analogous patents are still pending in Europe. SBFM is the sole owner of all intellectual property rights pertaining to Adva-27a, including the first Adva-27a patent (US Patent Number 8,236,935) issued in 2012.

 SBFM Completes Application to Uplist to OTCQB

On January 27th SBFM announced that it has successfully completed and submitted the application to uplist to the OTCQB. While SBFM is currently a fully reporting issuer trading on OTC Markets PINK, management has determined that an uplist to OTCQB is aligned with the Company's overall growth trajectory as it will allow institutional investors to participate.

 SBFM Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment

On January 14th SBFM announced that it has received the fourth tranche of funding under the recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $1,050,000 that SBFM has received to date under this financing. The proceeds will be used for the ongoing development of the SBFM Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the Company's flagship anticancer compound targeted for pancreatic cancer.

 SBFM Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK

On December 22nd SBFM announced that its Anti-Coronavirus drug development program is unaffected by the recent discovery of a new strain of Coronavirus in Southern England. The new strain appears to be more easily transmissible due to a mutation in the Spike Protein, the crown-like structure on the surface of the virus which allows it to gain entry into the host cell.

The SBFM Anti-Coronavirus compound, SBFM-PL4, acts on the Coronavirus Papain-Like Protease (PLpro) which is a non-structural protein encoded by the viral genome and synthesized by the hijacked protein synthesis machinery of the host cell. SBFM-PL4 inhibits PLpro and arrests viral replication. SBFM-PL4 is expected to inhibit the PLpro of the UK variant just as well as it does the original strain since the UK strain does not show any mutations in the PLpro gene.

 New Batch of Adva-27a for Testing on TOPII Amplified Cancers

On December 8th SBFM announced that it has ordered a new batch of Adva-27a from its manufacturer in China. The material will be delivered to the laboratories of the SBFM drug development partner in Montreal (Canada). SBFM plans to use the material to conduct testing on various types of cancer cells that overproduce Topoisomerase II (TopII). Following these cell culture studies, SBFM will proceed to performing studies on mice harboring tumors of human origin with TopII amplification. TopII is an essential cell cycle enzyme that is amplified in approximately 4% of all human cancers. All cancer types that have amplification of the Topoisomerase II gene are potential new targets for the SBFM Adva-27a. This is an additional application for Adva-27a beyond the original multidrug resistance indication.

 SBFM Pays Off Convertible Notes in Cash Preventing New Shares from Hitting the Market

On December 3rd SBFM announced that it has paid off just over $100,000 worth of convertible notes associated with the company. The Board of Directors deemed this action to be a priority for the in order to mitigate dilutive conversions and maximize shareholder value.

 SBFM Receives Third Tranche from Previously Announced $2,000,000 + Financing for Coronavirus Treatment

On December 1st SBFM announced that it has received the third tranche of funding under a recently announced committed minimum financing of $2,000,000 with RB Capital Partners Inc. This brings the total to $800,000 that SBFM has received under this financing. The proceeds will be used for the ongoing development of the SBFM Coronavirus Treatment on a priority basis and the clinical development of Adva-27a, the company's flagship anticancer compound targeted for pancreatic cancer.

For more information on Sunshine Biopharma (SBFM) visit: http://www.sunshinebiopharma.com

DISCLAIMER: FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. FPS/CA is NOT affiliated in any manner with any company mentioned herein. FPS/CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FPS/CA has been compensated $500 by the company for dissemination of this Article.

Disclaimer/Safe Harbor:

These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
SOURCE: CorporateAds.com

SBFM
SUNSHINE BIOPHARMA INC
+1 514-426-6161
email us here
Visit us on social media:
Twitter

SBFM – Sunshine Biopharma Inc. Stock Investor Daily


Source: EIN Presswire

Matthew Keezer on Traveling to U.S. Virgin Islands in 2021

Matthew Keezer

Matthew Keezer

Matthew Keezer, a former travel exec gives us insights on US Virgin Islands.

MONTREAL, QUEBEC, CANADA, March 2, 2021 /EINPresswire.com/ — After all travel was interrupted for a year or so, more and more popular destinations are accepting travelers from across the globe. One of those destinations is the U.S. Virgin Islands. The destination has reopened to travel with enhanced health and safety protocols in place.
U.S. Virgin Islands is one of the most sought-after locations in the Caribbean and also one of the most accessible destinations to Americans who won't need a passport to visit or a negative COVID-19 test result to return home. However, Matthew Keezer points out that there are a few things travelers should keep in mind before booking their trip.

Staying Up to Date with Latest News

According to the Centers for Disease Control and Prevention (CDC), U.S. Virgin Islands belongs to a Level 4 destination. This means all travelers should avoid visiting the islands due to the high number of people infected with COVID-19. As of February 23, the islands have reported fewer than 2,600 total coronavirus cases.

As Matthew Keezer points out, traveling to any destination can be safe as long as the travelers respect certain measures, such as wearing a mask at all times and proper social distancing. Those who decide to visit U.S. Virgin Islands should test for COVID-19 before and after their trip, practice social distancing, and avoid crowds.

Travel Requirements

All those who would like to visit the U.S. Virgin Islands will first have to obtain certification through the USVI Travel Screening Portal. In order to do so, travelers have to submit a negative COVID-19 molecular or antigen test result taken within five days of travel to the islands.
It is also possible to gain entry with a positive COVID-19 antibody finger stick or blood draw test taken within four months of travel to the U.S. Virgin Islands. Matthew Keezer points out that currently, quarantine is not required, but travelers should check local regulations before they book a trip.

Enhanced Health and Safety Protocols

To prevent coronavirus from spreading and to keep both locals and travelers safe, U.S. Virgin Islands has plenty of enhanced health and safety protocols. From the very moment they step off of the plane, travelers (age two and older) have to wear masks and undergo temperature checks.
Social distancing guidelines and improved cleaning standards are also prevalent in all locations, including hotels, resorts, restaurants, and other attractions. The U.S. Virgin Islands has more travel protocols and restrictions in place now than ever before, but they are not too demanding. And, most importantly, all the restrictions will keep travelers as safe as possible. The U.S. Virgin Islands is a beautiful destination, "COVID-19 will undoubtedly linger for a bit longer, but travel is still possible with some inconveniences.” Matthew explains.

Shared Media
Shared Media Inc
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

EDRM Announces Ankura as Newest Partner

EDRM

Setting the global standards for e-discovery

Ankura

Ankura

Our EDRM community is excited to partner with Ankura and to learn more about their innovative research applied to today’s legal data challenges.”

— Mary Mack, CEO, EDRM

MINNEAPOLIS, MINNESOTA, UNITED STATES, March 2, 2021 /EINPresswire.com/ — Setting the global standards for e-discovery, the Electronic Discovery Reference Model (EDRM) is pleased to announce Ankura Consulting Group LLC, a global business advisory and expert services firm, as its newest partner.

Among the EDRM opportunities and resources available to partners such as Ankura is the development and promotion of thought leadership and best practices in e-discovery, the distribution of unique content and the engagement of a global community comprised of knowledgeable, multidisciplinary professionals contributing to enhance e-discovery, privacy, security and information governance frameworks, processes and standards.

“My clients have benefited from the research Ankura and my Sidley team have done to ground our legal intuition in transparent analytics,” said Robert Keeling, partner and co-chair of the eDiscovery Group at Sidley and EDRM’s chair of the global advisory council. “The research not only grounds the legal intuition but also debunked some popular e-discovery myths.”

“Ankura is keenly focused on bringing advanced analytics transparency to the legal community,” said Mary Mack, CEO and chief legal technologist at EDRM. “Our EDRM community is excited to partner with them and to learn more about their innovative research applied to today’s legal data challenges.”

This partnership provides Ankura access to the global EDRM community, comprised of 33% corporations, 30% law firms and 23% software and service providers in 113 countries across six continents.

“We are excited to collaborate with the EDRM to help further bridge the gap between the legal community and academic research that studies the effectiveness of deploying advanced analytics on data in legal matters,” said Nathaniel Huber-Fliflet, senior managing director at Ankura Consulting Group. “We are looking forward to participating in an open and thoughtful dialogue about legal technology and helping drive analytics best practices in the industry.”

For those interested in an emerging technology-assisted review issue – the belief that machines are “just as good as” lawyers and that the machines’ results are superior to that of lawyers – Ankura and co-authors at AT&T Services, Inc. and Sidley Austin LLP will present their new research showing that predictive coding is not simply “better than” humans. Please save the date for April 14 at 1 p.m. EDT.

About Ankura
Ankura is a global advisory and expert services firm that designs, develops and executes tailored solutions for its clients. With particular focus on risk management, global compliance, disputes and investigation, Ankura delivers unique insights and experience across a wide range of economic, governance and regulatory challenges. For more information, please visit: www.ankura.com.

About EDRM
Empowering the global leaders of e-discovery, the Electronic Discovery Reference Model (EDRM) creates practical resources to improve e-discovery, privacy, security and information governance. Since 2005, EDRM has delivered leadership, standards, tools, guides and test datasets to improve best practices throughout the world. EDRM has an international presence in 113 countries and growing and an innovative support infrastructure for individuals, law firms, corporations and government organizations seeking to improve the practice and provision of data and legal discovery. Learn more about the EDRM today at EDRM.net.

Kaylee Walstad
EDRM
+16515527753 ext.
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

HIP Video Promo presents: Karma and Jack Rayner release an emotional new music video "Hold On Me – Jack Rayner Remix"

Karma, Jack Rayner

Karma, Jack Rayner – “Hold On Me – Jack Rayner Remix”

The clip for the original song sees a stark-faced Karma singing expressively to the camera, framed by an inky blackness that mirrors her emotional state.

SOUTH AFRICA, March 2, 2021 /EINPresswire.com/ — Sometimes the most rewarding songs for an electronic artist to remix are the ones that aren't adjacent to the club in the slightest. The initial version of Karma's "Hold on Me" is a slow-building ballad, lovelorn and heartbroken – a track designed for highway drives and late-night reflections. But when Karma called on producer Jack Rayner to remix the song, he quickly delivered a re-invented version worthy of its own music video and release. Jack manages to keep the small-hours intensity of the original while escalating the urgency with anthemic trap drums, hypnotic lo-fi synth lines, and majestic organ chords. The result is a track that's every bit as arresting as the original but with its relatable subject matter of "letting go" laid bare.

Writing songs that run deep is second nature for Karma-Ann Swanepoele, known simply as Karma, who has been a creative force in South African pop-rock for more than a decade. A talented amalgamator of folk styles: Slap in the Face, the 1996 debut set by Henry Ate, the band she fronted, continues to inspire young musicians and songwriters in Johannesburg, Pretoria, and beyond. Karma is a pioneer in the LGBTQ community, being an "out" celebrity in a time when there were very few, if any, at her status in the industry. The artist moved to the United States in the mid-'00s, but she never stopped making music, and her collaboration with Jack Rayner on "Hold On Me" is the latest contribution to a deep discography that stands as a testament to the breadth of her talent. In Jack Rayner, she's found a collaborator with a similar track record of accomplishment. The Los Angeles-based producer has remixed music for industry giants including Katy Perry and Britney Spears and worked on music for international series including American Idol, America's Got Talent, and World Of Dance.

Crossing the lines of his production worlds, Jack called upon the lead dancer of Magic Mike Live Berlin (of which Rayner is music producer) Kalon Badenhorst to bring his movement to the video for "Hold On Me." A winner of South Africa's Got Talent, Kalon is heavily featured in the haunting video clip bridging a generation gap of SA talent. The clip for the original song sees a stark-faced Karma singing expressively to the camera, framed by an inky blackness that mirrors her emotional state. A true "Jack of All Trades," Rayner combined footage of Kalon dancing to Karma's original video resulting in a remix video nothing short of breathtaking. Kalon expresses torment and regret through his dancing as Karma sings, "I've lived this life once before, and it almost killed me." Like a boxer on the ropes, he seems almost broken in moments, but by the end of the clip, he's still standing.

More Karma on Facebook
More Jack Rayner on Instagram
More Karma and Jack Rayner on HIP Video Promo

Andrew Gesner
HIP Video Promo
+1 732-613-1779
email us here


Source: EIN Presswire

2 Million Pages of Preschool Printables and Worksheets have been Downloaded in 190 Countries from Abby the Pup

Abby the Pup Free Preschool Printables and Worksheets

Abby the Pup Running, Playing and Sleeping

Abby the Pup

Abby the Pup

Preschool educational materials should be freely and publicly available to help educate our young children across the world

NEW YORK, NY, UNITED STATES, March 2, 2021 /EINPresswire.com/ — Abby the Pup is pleased to announce that tens of thousands of teachers and parents have already downloaded over 2 million pages of its preschool printables and worksheets from its website, www.abbythepup.com, since its launch in January. The website was developed in response to the global Covid-19 pandemic, when many young children were not able to go to school. They had to either learn remotely, were home schooled, or worse, did not have the opportunity and resources to learn at all. It continues to be a stressful time for teachers, parents and children.

Abby the Pup’s popularity is attributed to many factors:
• All content is provided free under the Creative Commons Public Domain Dedication
• The website has been designed to be extremely easy to navigate and use
• It is a safe and commercial free environment, with no registrations, no logins and no advertisements
• The content is interesting, fun and colorful to encourage learning
• Abby the Pup’s mission is for social good, with no commercial interests

There are over 1,000 pages of free preschool printables and worksheets. The content is organized into four categories of PDF documents which may be easily downloaded, printed and shared:

Literature – Alphabet Identification, Alphabet Trace and Write, Alphabet Worksheets, Alphabet Activities, Match Letters, Sight Words, Word Recognition, Rhyming Words, Word Families, Missing Letters

Math – Number Identification, Number Trace and Write, Number Worksheets, Match Numbers, Counting, Addition, Subtraction, Comparing, Ten Frame Cards, Patterns

General Knowledge and Skills – Colors, Shapes, Color Cute Animals, Coloring for Fun, Tracing, Matching Worksheets, Matching Cards, Positions, Sizes, Dot to Dot, Cut and Paste

Classroom – Pre-school Assessment, Awards, Calendar, Name Cards, Center Signs, Nursery Rhymes, Posters, The Week, Reward Cards, Draw in Frame, Science Activity Plans

Abby the Pup believes that quality preschool educational materials should be freely available to all children. Education helps lift children out of poverty, addresses social inequalities and provides a path to a better life. The company encourages the distribution and sharing of this content to help educate and improve the lives of young children across the world.

For more information, please visit www.abbythepup.com.

About Abby the Pup:
Abby the Pup was created in 2020 during the Covid-19 pandemic. Many young children could not go to school or were required to learn remotely from home. It was a stressful time for children, parents and teachers. Out of this crisis came the inspiration. Why must educational materials be so difficult to access, costly and commercialized? It should be easy to use and freely available in the public domain to help teachers and parents educate their young children. This is the mission of Abby the Pup.

Larry Ng
Abby the Pup
lovetolearn@abbythepup.com


Source: EIN Presswire

Gerstenberg.clinic now offering revolutionary Acoustic Wave therapy as part of their Erectile Dysfunction Relief Program

Dr. Gerstenberg of gerstenberg.clinic in a white doctor's coat with arms crossed.

K. Paul Gerstenberg, D.O.

gerstenberg.clinic logo with icon and address (2645 Nall St, Port Neches, TX 77651)

Gerstenberg.clinic is now offering state-of-the-art Acoustic Wave Therapy for improving erectile dysfunction. Call to schedule a free consultation.

I came to Dr. Gerstenberg for erectile issues and pretty bad Peyronie's problems… After a single P-shot® and shockwave treatment, we were able to be intimate for the first time in 6 years.”

— Patient of Dr. Gerstenberg

PORT NECHES, TEXAS, USA, March 2, 2021 /EINPresswire.com/ — Dr. K. Paul Gerstenberg is proud to announce that gerstenberg.clinic is now the only area provider offering both the P-shot® and Acoustic Wave treatment. Both are drug-free, non-invasive medical procedures to help improve Erectile Dysfunction (E.D.).

Acoustic Wave Therapy (sometimes referred to as ‘pulse wave therapy’ or ‘shockwave therapy’) handles E.D. on a cellular level to improve natural spontaneity for any man. Treatment is performed with a device that uses acoustic sound waves (a.k.a. Low-intensity, extracorporeal shockwave therapy or ESWT). This addresses the cause of physiological erectile dysfunction by breaking up plaque and blockages, and increasing blood flow by creating new blood vessels. Thus, the 3 primary causes of vasculogenic E.D. are addressed by the body’s natural healing agents, and there are absolutely no side effects.

Acoustic Wave Therapy provides E.D. patients a solution without the use of drugs, surgery, injections or accessories. Gerstenberg.clinic's device is from Medical Wave, a company specializing in the world’s most effective EPAT and Shockwave Technology, reporting a 91% success rate according to clinical studies.

Dr. Gerstenberg emphasized that Acoustic Wave Therapy is often even more effective if used in conjunction with other alternative therapies such as the P-shot®, which Dr. G also provides at gerstenberg.clinic. The P-shot® uses PRP (platelet-rich plasma) to draw the body’s own healing factors in a concentrated effort to the penile tissue. He says, “I’ve seen patients who choose to combine both these therapies end up with quicker and more thorough results. Treating the issue in this synergistic manner gives the body its best shot to repair the damage that comes with age.”

As one patient said, “I came to Dr. Gerstenberg for erectile issues and pretty bad Peyronie's problems that have gradually got worse and worse. After a single P-shot® and shockwave treatment, we were able to be intimate for the first time in 6 years. Wow! We were amazed. By using all the treatment modes he has given, our good marriage is great again! If your relationship is suffering, I'd suggest you get with Dr. G at gerstenberg.clinic."

For long-term success, each patient’s journey will be different, but gerstenberg.clinic is committed to determine the underlying cause(s) and walk with you the entire way. Causes could be a combination of mental and physical factors, one of which might be hormonal imbalance, which they could also address through testosterone optimization or BioTE®. Whatever you are experiencing, and whatever the cause, they will work with you to develop a treatment plan for long-term health and confidence.

Gerstenberg.clinic has helped many patients in the Southeast Texas area live life to the fullest by providing non-surgical, natural treatment options. Pain reduction (including osteoarthritic and orthopedic), increased energy, and improved male and female sexual wellness are just some of the results their patients have seen. And the best part is that they don’t treat patients who they don’t expect to see results from; treatment plans are tailor-made and closely monitored for optimal results.

While very new in the US, Acoustic Wave Therapy has been used successfully in Europe for years. Gerstenberg.clinic is now treating men with the Acoustic Wave device in their office at 2645 Nall Street, Port Neches, TX, 77651. Find more information about Acoustic Wave Therapy at www.gerstenberg.clinic or contact us to see how gerstenberg.clinic can help you today!

K. Paul Gerstenberg, D.O.
gerstenberg.clinic
+1 409-210-3336
clinic@gerstenbergclinic.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire